SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical Use
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 3U01CA260584-02S1
Grant search
Key facts
Disease
COVID-19Start & end year
20202025Known Financial Commitments (USD)
$194,620Funder
National Institutes of Health (NIH)Principal Investigator
SENIOR PHYSICIAN/RESEARCH SCIENTIST Jacek SkarbinskiResearch Location
United States of AmericaLead Research Institution
KAISER FOUNDATION RESEARCH INSTITUTEResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Vulnerable populations unspecified
Occupations of Interest
Unspecified
Abstract
We propose a two-year collaborative project to synchronize data harmonization efforts and analyses of individual-level data in immunocompromised populations to assess effectiveness of vaccine boosters and immune responses using data from 11 Serological Sciences Network (SeroNet) institutions. Our goal is to inform public health guidelines on COVID-19 vaccine and boosters to reduce SARS-CoV-2 infection and severe illness in these vulnerable populations.